RUVBL1 and non-small cell lung carcinoma: RUVBL1 mRNA high vs. low expression was found to be related to a significantly shorter OS for NSCLC patients (median OS of 1778 vs.1632 days, respectively; HR = 1.33, 95%CI 1.05–1.69; p = 0.018; Table 4).